Literature DB >> 12737517

Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein.

Yi Hu Xie1, Xiang Huo He, Yun Tian Tang, Jin Jun Li, Zhi Mei Pan, Wen Xin Qin, Da Fang Wan, Jian Ren Gu.   

Abstract

We have identified IC53-2, a human homologue of the rat C53 gene from a human placenta cDNA library (GeneBank Accession No.AF217982). IC53-2 can bind to the CDK5 activator p35 by in vitro association assay. IC53-2 is mapped to human chromosome 17q21.31. The IC53-2 transcript is highly expressed in kidney, liver, skeletal muscle and placenta. It is abundantly expressed in SMMC-7721, C-33A, 3AO, A431 and MCF-7 cancer cell lines by RT-PCR assay. Stable transfection of IC53-2 cDNA into the hepatocellular carcinoma SMMC-7721 cell remarkably stimulates its growth in vitro. The above results indicate that IC53-2 is a novel human gene, which may be involved in the regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737517     DOI: 10.1038/sj.cr.7290153

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  2 in total

1.  Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.

Authors:  Jian-Xian Lin; Xin-Sheng Xie; Xiong-Feng Weng; Sheng-Liang Qiu; Jian-Wei Xie; Jia-Bin Wang; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ping Li; Chang-Ming Huang; Chao-Hui Zheng
Journal:  Oncol Rep       Date:  2019-03-05       Impact factor: 3.906

2.  Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes.

Authors:  Michael Song; Xiaoyu Yang; Xingjie Ren; Lenka Maliskova; Bingkun Li; Ian R Jones; Chao Wang; Fadi Jacob; Kenneth Wu; Michela Traglia; Tsz Wai Tam; Kirsty Jamieson; Si-Yao Lu; Guo-Li Ming; Yun Li; Jun Yao; Lauren A Weiss; Jesse R Dixon; Luke M Judge; Bruce R Conklin; Hongjun Song; Li Gan; Yin Shen
Journal:  Nat Genet       Date:  2019-07-31       Impact factor: 38.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.